Back
ESC2025 Premium Access

Can HALP help in identifying transcatheter aortic valve replacement patients at risk?

Session: Aortic stenosis: cause, treatment, and outcome
Topic: Aortic Valve Stenosis
Speaker: Doctor P. Bistrovic (Zagreb, HR)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Petra Bistrovic

University Hospital Dubrava, Zagreb (Croatia)
1 presentation
0 follower

6 more presentations in this session

Inflammatory burden index and mortality following transcatheter aortic valve replacement

Speaker: Doctor S. Kikuchi (Strasbourg, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Association between deployment depth eccentricity index and hypo-attenuated leaflet thickening after transcatheter aortic valve replacement

Speaker: Professor Y. Li (Xi'an, CN)

Access
Abstract
Slides
Video
Like
Thumbnail

The impact of loop diuretics reduction on heart failure rehospitalization in post-TAVR patients

Speaker: Doctor K. Takegawa (Suita, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Awake-TAVI: Impact of anesthesia techniques on peri- and postoperative outcomes in TAVI patients

Speaker: Doctor R. Phinicarides (Duesseldorf, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Utility of PCI in patients with coronary artery disease and aortic stenosis undergoing TAVI

Speaker: Doctor S. Gupta (Stony Brook, US)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Aortic stenosis: cause, treatment, and outcome

Speakers: Doctor P. Bistrovic, Doctor S. Kikuchi, Professor Y. Li, Doctor K. Takegawa, Doctor R. Phinicarides...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources